Literature DB >> 21479826

TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.

Federica Rossin1, Manuela D'Eletto, Douglas Macdonald, Maria Grazia Farrace, Mauro Piacentini.   

Abstract

Tissue transglutaminase (TG2) activity has been implicated in inflammatory disease processes such as Celiac disease, infectious diseases, cancer, and neurodegenerative diseases, such as Huntington's disease. Furthermore, four distinct biochemical activities have been described for TG2 including protein crosslinking via transamidation, GTPase, kinase and protein disulfide isomerase activities. Although the enzyme plays a complex role in the regulation of cell death and autophagy, the molecular mechanisms and the putative biochemical activity involved in each is unclear. Therefore, the goal of the present study was to determine how TG2 modulates autophagy and/or apoptosis and which of its biochemical activities is involved in those processes. To address this question, immortalized embryonic fibroblasts obtained from TG2 knock-out mice were reconstituted with either wild-type TG2 or TG2 lacking its transamidating activity and these were subjected to different treatments to induce autophagy or apoptosis. We found that knock out of the endogenous TG2 resulted in a significant exacerbation of caspase 3 activity and PARP cleavage in MEF cells subjected to apoptotic stimuli. Interestingly, the same cells showed the accumulation of LC3 II isoform following autophagy induction. These findings strongly suggest that TG2 transamidating activity plays a protective role in the response of MEF cells to death stimuli, because the expression of the wild-type TG2, but not its transamidation inactive C277S mutant, resulted in a suppression of caspase 3 as well as PARP cleavage upon apoptosis induction. Additionally, the same mutant was unable to catalyze the final steps in autophagosome formation during autophagy. Our findings clearly indicate that the TG2 transamidating activity is the primary biochemical function involved in the physiological regulation of both apoptosis and autophagy. These data also indicate that TG2 is a key regulator of cross-talk between autophagy and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21479826     DOI: 10.1007/s00726-011-0899-x

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  18 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

2.  The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.

Authors:  Sara Altuntas; Federica Rossin; Claudia Marsella; Manuela D'Eletto; Laura Diaz-Hidalgo; Maria Grazia Farrace; Michelangelo Campanella; Manuela Antonioli; Gian Maria Fimia; Mauro Piacentini
Journal:  Oncotarget       Date:  2015-12-29

3.  Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis.

Authors:  F Rossin; M D'Eletto; L Falasca; S Sepe; S Cocco; G M Fimia; M Campanella; P G Mastroberardino; M G Farrace; M Piacentini
Journal:  Cell Death Differ       Date:  2014-07-25       Impact factor: 15.828

4.  Transglutaminase 2: a new player in bronchopulmonary dysplasia?

Authors:  Thilo J Witsch; Gero Niess; Elpidoforos Sakkas; Tatyana Likhoshvay; Simone Becker; Susanne Herold; Konstantin Mayer; István Vadász; Jesse D Roberts; Werner Seeger; Rory E Morty
Journal:  Eur Respir J       Date:  2014-03-06       Impact factor: 16.671

5.  TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2.

Authors:  Mireille Delhase; Soo-Youl Kim; Ho Lee; Aya Naiki-Ito; Yi Chen; Eu-Ree Ahn; Kazuhiro Murata; Se-Jin Kim; Norman Lautsch; Koichi S Kobayashi; Tomoyuki Shirai; Michael Karin; Makoto Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

Review 6.  Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.

Authors:  Breandan R Quinn; Laura Yunes-Medina; Gail V W Johnson
Journal:  J Neurosci Res       Date:  2018-03-23       Impact factor: 4.164

7.  Transglutaminase type 2: A multifunctional protein chaperone?

Authors:  Federica Rossin; Manuela D'Eletto; Maria Grazia Farrace; Mauro Piacentini
Journal:  Mol Cell Oncol       Date:  2014-12-31

8.  Inhibition of transglutaminase exacerbates polyglutamine-induced neurotoxicity by increasing the aggregation of mutant ataxin-3 in an SCA3 Drosophila model.

Authors:  Yunting Lin; Hua He; Yingying Luo; Ting Zhu; Ranhui Duan
Journal:  Neurotox Res       Date:  2014-12-11       Impact factor: 3.911

9.  TG2 regulates the heat-shock response by the post-translational modification of HSF1.

Authors:  Federica Rossin; Valeria Rachela Villella; Manuela D'Eletto; Maria Grazia Farrace; Speranza Esposito; Eleonora Ferrari; Romina Monzani; Luca Occhigrossi; Vittoria Pagliarini; Claudio Sette; Giorgio Cozza; Nikolai A Barlev; Laura Falasca; Gian Maria Fimia; Guido Kroemer; Valeria Raia; Luigi Maiuri; Mauro Piacentini
Journal:  EMBO Rep       Date:  2018-05-11       Impact factor: 8.807

10.  Loss of collagen VII is associated with reduced transglutaminase 2 abundance and activity.

Authors:  Victoria Küttner; Claudia Mack; Christine Gretzmeier; Leena Bruckner-Tuderman; Jörn Dengjel
Journal:  J Invest Dermatol       Date:  2014-04-14       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.